α-Glucosidase-IN-112
α-Glucosidase-IN-112 is an α-glucosidase inhibitor with an IC50 of 2.03 μM and a Ki of 0.44 μM. α-Glucosidase-IN-112 exerts antioxidant effects by scavenging ABTS+ free radicals. α-Glucosidase-IN-112 exerts antiproliferative effects by inhibiting the proliferation of bladder cancer cells. α-Glucosidase-IN-112 can be used in research related to type 2 diabetes and bladder cancer.
For research use only. We do not sell to patients.
- Formula: C23H22N4O3S2
- Molecular Weight:466.58
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
α‑glucosidase 2.03 μM (IC50) |
α‑glucosidase 0.44 μM (Ki) |
α-Glucosidase-IN-112 (Compound 4i) (0-2.0 μM; 24 h) potently inhibits the proliferation of human T24 bladder cancer cells with an IC50 of 1.93 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:human T24 bladder cancer cells
-
Concentration:0, 0.5, 1, 1.5 and 2.0 μM
-
Incubation Time:24 h
-
Result:Inhibited T24 bladder cancer cell proliferation with an IC50 value of 1.93 μM, which is lower than the IC50 value of the positive control cisplatin.
Chemical Information
-
Molecular Weight 466.58
-
Formula C23H22N4O3S2
-
SMILES
O=S(C1=CC=C(/C(C)=N/NC(C2=CNC3=C2C=CC=C3)=O)C=C1)(NCCC4=CC=CS4)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)